Stavros E Mountantonakis
Overview
Explore the profile of Stavros E Mountantonakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Varrias D, Kossack A, Leavitt J, Chhetri C, Roselli V, Velichkovikj S, et al.
Heart Rhythm
. 2025 Mar;
PMID: 40057297
Background: The relationship between Obstructive sleep apnea (OSA) and Atrial fibrillation (AF) is well established as existing literature has concluded that sleep apnea creates a unique, complex, and dynamic substrate...
2.
Mountantonakis S, Gerstenfeld E, Mansour M, Cuoco F, Natale A, Patel C, et al.
Heart Rhythm
. 2025 Mar;
PMID: 40057295
Background: Pulsed field ablation (PFA) has proven to be at least non-inferior to thermal ablation for paroxysmal atrial fibrillation (PAF). Predictors of AF freedom for PFA have not yet been...
3.
Deisenhofer I, Albenque J, Busch S, Gitenay E, Mountantonakis S, Roux A, et al.
Nat Med
. 2025 Feb;
PMID: 39953289
Although pulmonary vein isolation (PVI) has become the cornerstone ablation procedure for atrial fibrillation (AF), the optimal ablation procedure for persistent and long-standing persistent AF remains elusive. Targeting spatio-temporal electrogram...
4.
Kiehl E, Mountantonakis S, Mansour M, Nair D, Sharma D, Taigen T, et al.
Heart Rhythm
. 2025 Feb;
PMID: 39922404
Background: The SPHERE Per-AF trial demonstrated noninferiority for a primary composite effectiveness endpoint in patients with persistent atrial fibrillation (AF) treated with a 9-mm, lattice-tip, pulsed field (PF)/radiofrequency (RF) system...
5.
Mountantonakis S, Bekiaridou A, Sharma N, Coleman K
JACC Clin Electrophysiol
. 2024 Dec;
10(12):2740.
PMID: 39722246
No abstract available.
6.
Sharma N, Coleman K, Cunn G, Kleiman J, Kossack A, Bimal T, et al.
J Cardiovasc Electrophysiol
. 2024 Nov;
36(2):314-322.
PMID: 39611509
Introduction: Ventricular premature depolarizations (VPDs) in the setting of acute coronary syndrome (ACS) were associated with increased hospital mortality in the early revascularization era. Objective: Examine the predictive value of...
7.
Vlachakis P, Theofilis P, Apostolos A, Kordalis A, Sideris S, Leventopoulos G, et al.
Heart Fail Rev
. 2024 Nov;
30(2):365-380.
PMID: 39579301
Heart failure (HF) is a major clinical challenge characterized by significant morbidity and mortality. Electrical conduction abnormalities play a critical role in HF pathophysiology and progression, often leading to suboptimal...
8.
Kleiman J, Varrias D, Varkey A, Young A, Wolf E, Gasparis C, et al.
Heart Rhythm O2
. 2024 Sep;
5(8):597-600.
PMID: 39263610
No abstract available.
9.
Saleh M, Coleman K, Fishbein J, Gandomi A, Yang B, Kossack A, et al.
Heart Rhythm
. 2024 Jun;
21(9):1658-1668.
PMID: 38823670
Background: It is unclear whether advances in management of acute coronary syndrome (ACS) and introduction of novel oral anticoagulants have changed outcomes in patients with ACS with concomitant atrial fibrillation...
10.
Makker P, Coleman K, Varrias D, Gabriels J, Cunn G, Saleh M, et al.
J Interv Card Electrophysiol
. 2024 May;
67(7):1671-1673.
PMID: 38739249
No abstract available.